National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 382966

History of Changes from the VAERS Wayback Machine

First Appeared on 4/7/2010

VAERS ID: 382966
VAERS Form:
Age:0.3
Sex:Female
Location:Foreign
Vaccinated:2007-12-14
Onset:2008-04-04
Submitted:2010-03-18
Entered:2010-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal distension, Abdominal pain, Barium double contrast, Dehydration, Faeces discoloured, Haematochezia, Intussusception, Sepsis, Vomiting, X-ray abnormal, Rectal examination, Ileocolostomy, Intestinal resection, Gastrointestinal motility disorder, Abdominal X-ray

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 32     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal x-ray, Apr2008, see text
CDC 'Split Type': B0639148A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 7-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included 10 valent pneumococcal conjugate vaccine (manufacturer unspecified, intramuscular, unknown injection site) given on 22 August 2007; BCG (non-GSK) (manufacturer unspecified, intradermal, unknown injection site) given on 15 August 2007; HEP B (manufacturer unspecified, intramuscular, unknown injection site) given on 15 August 2007, 22 October 2007 and 18 February 2008; 1st dose of ROTARIX (1 ml, oral) given on 22 October 2007. On 14 December 2007, the subject received 2nd dose of ROTARIX (1 ml, oral). On 4 April 2008, 112 days after vaccination with ROTARIX, the subject experienced abdominal pain, blood in stools, abdominal distension, biliary vomiting. The subject was admitted into emergency room same day and found abdominal distention, dehydrated, abdominal pain, no peristalsis, rectal examination with "blackcurrant" evacuations and palpate intestine in reverse. The subject was hospitalised and the physician considered the events were clinically significant (or requiring intervention). A plain abdominal x-Ray was performed. It did not showed a visible intussusception or soft tissue mass. It showed fluid levels and dilated bowel loops. The plain abdominal x-ray with air or liquid contrast enema did not demonstrated invagination of the intestine. The plain abdominal x-ray showed non-specific abnormalities. The result of this exam was a suspicious ileocolic invagination. An abdominal ultrasound was not performed. An abdominal CT was not performed. The subject was treated with surgery (intestinal resection and ileocolostomy) without complications. After surgery, the subject presented sepsis, recovering and was discharged on 6 May 2008. At the time of reporting the events were resolved. The physician considered the events were almost certainly related to vaccination with ROTARIX.


Changed on 5/13/2013

VAERS ID: 382966 Before After
VAERS Form:
Age:0.3
Sex:Female
Location:Foreign
Vaccinated:2007-12-14
Onset:2008-04-04
Submitted:2010-03-18
Entered:2010-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 - / PO
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal distension, Abdominal pain, Barium double contrast, Dehydration, Faeces discoloured, Haematochezia, Intussusception, Sepsis, Vomiting, X-ray abnormal, Rectal examination, Ileocolostomy, Intestinal resection, Gastrointestinal motility disorder, Abdominal X-ray

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 32     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal x-ray, Apr2008, see text
CDC 'Split Type': B0639148A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 7-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included 10 valent pneumococcal conjugate vaccine (manufacturer unspecified, intramuscular, unknown injection site) given on 22 August 2007; BCG (non-GSK) (manufacturer unspecified, intradermal, unknown injection site) given on 15 August 2007; HEP B (manufacturer unspecified, intramuscular, unknown injection site) given on 15 August 2007, 22 October 2007 and 18 February 2008; 1st dose of ROTARIX (1 ml, oral) given on 22 October 2007. On 14 December 2007, the subject received 2nd dose of ROTARIX (1 ml, oral). On 4 April 2008, 112 days after vaccination with ROTARIX, the subject experienced abdominal pain, blood in stools, abdominal distension, biliary vomiting. The subject was admitted into emergency room same day and found abdominal distention, dehydrated, abdominal pain, no peristalsis, rectal examination with "blackcurrant" evacuations and palpate intestine in reverse. The subject was hospitalised and the physician considered the events were clinically significant (or requiring intervention). A plain abdominal x-Ray was performed. It did not showed a visible intussusception or soft tissue mass. It showed fluid levels and dilated bowel loops. The plain abdominal x-ray with air or liquid contrast enema did not demonstrated invagination of the intestine. The plain abdominal x-ray showed non-specific abnormalities. The result of this exam was a suspicious ileocolic invagination. An abdominal ultrasound was not performed. An abdominal CT was not performed. The subject was treated with surgery (intestinal resection and ileocolostomy) without complications. After surgery, the subject presented sepsis, recovering and was discharged on 6 May 2008. At the time of reporting the events were resolved. The physician considered the events were almost certainly related to vaccination with ROTARIX.


Changed on 2/14/2017

VAERS ID: 382966 Before After
VAERS Form:
Age:0.3 0.33
Sex:Female
Location:Foreign
Vaccinated:2007-12-14
Onset:2008-04-04
Submitted:2010-03-18
Entered:2010-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal distension, Abdominal pain, Barium double contrast, Dehydration, Faeces discoloured, Haematochezia, Intussusception, Sepsis, Vomiting, X-ray abnormal, Rectal examination, Ileocolostomy, Intestinal resection, Gastrointestinal motility disorder, Abdominal X-ray

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 32     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal x-ray, Apr2008, see text
CDC 'Split Type': B0639148A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 7-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included 10 valent pneumococcal conjugate vaccine (manufacturer unspecified, intramuscular, unknown injection site) given on 22 August 2007; BCG (non-GSK) (manufacturer unspecified, intradermal, unknown injection site) given on 15 August 2007; HEP B (manufacturer unspecified, intramuscular, unknown injection site) given on 15 August 2007, 22 October 2007 and 18 February 2008; 1st dose of ROTARIX (1 ml, oral) given on 22 October 2007. On 14 December 2007, the subject received 2nd dose of ROTARIX (1 ml, oral). On 4 April 2008, 112 days after vaccination with ROTARIX, the subject experienced abdominal pain, blood in stools, abdominal distension, biliary vomiting. The subject was admitted into emergency room same day and found abdominal distention, dehydrated, abdominal pain, no peristalsis, rectal examination with "blackcurrant" evacuations and palpate intestine in reverse. The subject was hospitalised and the physician considered the events were clinically significant (or requiring intervention). A plain abdominal x-Ray was performed. It did not showed a visible intussusception or soft tissue mass. It showed fluid levels and dilated bowel loops. The plain abdominal x-ray with air or liquid contrast enema did not demonstrated invagination of the intestine. The plain abdominal x-ray showed non-specific abnormalities. The result of this exam was a suspicious ileocolic invagination. An abdominal ultrasound was not performed. An abdominal CT was not performed. The subject was treated with surgery (intestinal resection and ileocolostomy) without complications. After surgery, the subject presented sepsis, recovering and was discharged on 6 May 2008. At the time of reporting the events were resolved. The physician considered the events were almost certainly related to vaccination with ROTARIX.


Changed on 9/14/2017

VAERS ID: 382966 Before After
VAERS Form:(blank) 1
Age:0.33
Sex:Female
Location:Foreign
Vaccinated:2007-12-14
Onset:2008-04-04
Submitted:2010-03-18
Entered:2010-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 2 - MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal distension, Abdominal pain, Barium double contrast, Dehydration, Faeces discoloured, Haematochezia, Intussusception, Sepsis, Vomiting, X-ray abnormal, Rectal examination, Ileocolostomy, Intestinal resection, Gastrointestinal motility disorder, Abdominal X-ray

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 32     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal x-ray, Apr2008, see text
CDC 'Split Type': B0639148A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 7-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included 10 valent pneumococcal conjugate vaccine (manufacturer unspecified, intramuscular, unknown injection site) given on 22 August 2007; BCG (non-GSK) (manufacturer unspecified, intradermal, unknown injection site) given on 15 August 2007; HEP B (manufacturer unspecified, intramuscular, unknown injection site) given on 15 August 2007, 22 October 2007 and 18 February 2008; 1st dose of ROTARIX (1 ml, oral) given on 22 October 2007. On 14 December 2007, the subject received 2nd dose of ROTARIX (1 ml, oral). On 4 April 2008, 112 days after vaccination with ROTARIX, the subject experienced abdominal pain, blood in stools, abdominal distension, biliary vomiting. The subject was admitted into emergency room same day and found abdominal distention, dehydrated, abdominal pain, no peristalsis, rectal examination with "blackcurrant" evacuations and palpate intestine in reverse. The subject was hospitalised and the physician considered the events were clinically significant (or requiring intervention). A plain abdominal x-Ray was performed. It did not showed a visible intussusception or soft tissue mass. It showed fluid levels and dilated bowel loops. The plain abdominal x-ray with air or liquid contrast enema did not demonstrated invagination of the intestine. The plain abdominal x-ray showed non-specific abnormalities. The result of this exam was a suspicious ileocolic invagination. An abdominal ultrasound was not performed. An abdominal CT was not performed. The subject was treated with surgery (intestinal resection and ileocolostomy) without complications. After surgery, the subject presented sepsis, recovering and was discharged on 6 May 2008. At the time of reporting the events were resolved. The physician considered the events were almost certainly related to vaccination with ROTARIX.


Changed on 2/14/2018

VAERS ID: 382966 Before After
VAERS Form:1
Age:0.33
Sex:Female
Location:Foreign
Vaccinated:2007-12-14
Onset:2008-04-04
Submitted:2010-03-18
Entered:2010-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal distension, Abdominal pain, Barium double contrast, Dehydration, Faeces discoloured, Haematochezia, Intussusception, Sepsis, Vomiting, X-ray abnormal, Rectal examination, Ileocolostomy, Intestinal resection, Gastrointestinal motility disorder, Abdominal X-ray

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 32     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal x-ray, Apr2008, see text
CDC 'Split Type': B0639148A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 7-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included 10 valent pneumococcal conjugate vaccine (manufacturer unspecified, intramuscular, unknown injection site) given on 22 August 2007; BCG (non-GSK) (manufacturer unspecified, intradermal, unknown injection site) given on 15 August 2007; HEP B (manufacturer unspecified, intramuscular, unknown injection site) given on 15 August 2007, 22 October 2007 and 18 February 2008; 1st dose of ROTARIX (1 ml, oral) given on 22 October 2007. On 14 December 2007, the subject received 2nd dose of ROTARIX (1 ml, oral). On 4 April 2008, 112 days after vaccination with ROTARIX, the subject experienced abdominal pain, blood in stools, abdominal distension, biliary vomiting. The subject was admitted into emergency room same day and found abdominal distention, dehydrated, abdominal pain, no peristalsis, rectal examination with "blackcurrant" evacuations and palpate intestine in reverse. The subject was hospitalised and the physician considered the events were clinically significant (or requiring intervention). A plain abdominal x-Ray was performed. It did not showed a visible intussusception or soft tissue mass. It showed fluid levels and dilated bowel loops. The plain abdominal x-ray with air or liquid contrast enema did not demonstrated invagination of the intestine. The plain abdominal x-ray showed non-specific abnormalities. The result of this exam was a suspicious ileocolic invagination. An abdominal ultrasound was not performed. An abdominal CT was not performed. The subject was treated with surgery (intestinal resection and ileocolostomy) without complications. After surgery, the subject presented sepsis, recovering and was discharged on 6 May 2008. At the time of reporting the events were resolved. The physician considered the events were almost certainly related to vaccination with ROTARIX.


Changed on 6/14/2018

VAERS ID: 382966 Before After
VAERS Form:1
Age:0.33
Sex:Female
Location:Foreign
Vaccinated:2007-12-14
Onset:2008-04-04
Submitted:2010-03-18
Entered:2010-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal distension, Abdominal pain, Barium double contrast, Dehydration, Faeces discoloured, Haematochezia, Intussusception, Sepsis, Vomiting, X-ray abnormal, Rectal examination, Ileocolostomy, Intestinal resection, Gastrointestinal motility disorder, Abdominal X-ray

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 32     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal x-ray, Apr2008, see text
CDC 'Split Type': B0639148A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 7-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included 10 valent pneumococcal conjugate vaccine (manufacturer unspecified, intramuscular, unknown injection site) given on 22 August 2007; BCG (non-GSK) (manufacturer unspecified, intradermal, unknown injection site) given on 15 August 2007; HEP B (manufacturer unspecified, intramuscular, unknown injection site) given on 15 August 2007, 22 October 2007 and 18 February 2008; 1st dose of ROTARIX (1 ml, oral) given on 22 October 2007. On 14 December 2007, the subject received 2nd dose of ROTARIX (1 ml, oral). On 4 April 2008, 112 days after vaccination with ROTARIX, the subject experienced abdominal pain, blood in stools, abdominal distension, biliary vomiting. The subject was admitted into emergency room same day and found abdominal distention, dehydrated, abdominal pain, no peristalsis, rectal examination with "blackcurrant" evacuations and palpate intestine in reverse. The subject was hospitalised and the physician considered the events were clinically significant (or requiring intervention). A plain abdominal x-Ray was performed. It did not showed a visible intussusception or soft tissue mass. It showed fluid levels and dilated bowel loops. The plain abdominal x-ray with air or liquid contrast enema did not demonstrated invagination of the intestine. The plain abdominal x-ray showed non-specific abnormalities. The result of this exam was a suspicious ileocolic invagination. An abdominal ultrasound was not performed. An abdominal CT was not performed. The subject was treated with surgery (intestinal resection and ileocolostomy) without complications. After surgery, the subject presented sepsis, recovering and was discharged on 6 May 2008. At the time of reporting the events were resolved. The physician considered the events were almost certainly related to vaccination with ROTARIX.


Changed on 8/14/2018

VAERS ID: 382966 Before After
VAERS Form:1
Age:0.33
Sex:Female
Location:Foreign
Vaccinated:2007-12-14
Onset:2008-04-04
Submitted:2010-03-18
Entered:2010-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal distension, Abdominal pain, Barium double contrast, Dehydration, Faeces discoloured, Haematochezia, Intussusception, Sepsis, Vomiting, X-ray abnormal, Rectal examination, Ileocolostomy, Intestinal resection, Gastrointestinal motility disorder, Abdominal X-ray

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 32     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal x-ray, Apr2008, see text
CDC 'Split Type': B0639148A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 7-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included 10 valent pneumococcal conjugate vaccine (manufacturer unspecified, intramuscular, unknown injection site) given on 22 August 2007; BCG (non-GSK) (manufacturer unspecified, intradermal, unknown injection site) given on 15 August 2007; HEP B (manufacturer unspecified, intramuscular, unknown injection site) given on 15 August 2007, 22 October 2007 and 18 February 2008; 1st dose of ROTARIX (1 ml, oral) given on 22 October 2007. On 14 December 2007, the subject received 2nd dose of ROTARIX (1 ml, oral). On 4 April 2008, 112 days after vaccination with ROTARIX, the subject experienced abdominal pain, blood in stools, abdominal distension, biliary vomiting. The subject was admitted into emergency room same day and found abdominal distention, dehydrated, abdominal pain, no peristalsis, rectal examination with "blackcurrant" evacuations and palpate intestine in reverse. The subject was hospitalised and the physician considered the events were clinically significant (or requiring intervention). A plain abdominal x-Ray was performed. It did not showed a visible intussusception or soft tissue mass. It showed fluid levels and dilated bowel loops. The plain abdominal x-ray with air or liquid contrast enema did not demonstrated invagination of the intestine. The plain abdominal x-ray showed non-specific abnormalities. The result of this exam was a suspicious ileocolic invagination. An abdominal ultrasound was not performed. An abdominal CT was not performed. The subject was treated with surgery (intestinal resection and ileocolostomy) without complications. After surgery, the subject presented sepsis, recovering and was discharged on 6 May 2008. At the time of reporting the events were resolved. The physician considered the events were almost certainly related to vaccination with ROTARIX.


Changed on 9/14/2018

VAERS ID: 382966 Before After
VAERS Form:1
Age:0.33
Sex:Female
Location:Foreign
Vaccinated:2007-12-14
Onset:2008-04-04
Submitted:2010-03-18
Entered:2010-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal distension, Abdominal pain, Barium double contrast, Dehydration, Faeces discoloured, Haematochezia, Intussusception, Sepsis, Vomiting, X-ray abnormal, Rectal examination, Ileocolostomy, Intestinal resection, Gastrointestinal motility disorder, Abdominal X-ray

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 32     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal x-ray, Apr2008, see text
CDC 'Split Type': B0639148A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 7-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included 10 valent pneumococcal conjugate vaccine (manufacturer unspecified, intramuscular, unknown injection site) given on 22 August 2007; BCG (non-GSK) (manufacturer unspecified, intradermal, unknown injection site) given on 15 August 2007; HEP B (manufacturer unspecified, intramuscular, unknown injection site) given on 15 August 2007, 22 October 2007 and 18 February 2008; 1st dose of ROTARIX (1 ml, oral) given on 22 October 2007. On 14 December 2007, the subject received 2nd dose of ROTARIX (1 ml, oral). On 4 April 2008, 112 days after vaccination with ROTARIX, the subject experienced abdominal pain, blood in stools, abdominal distension, biliary vomiting. The subject was admitted into emergency room same day and found abdominal distention, dehydrated, abdominal pain, no peristalsis, rectal examination with "blackcurrant" evacuations and palpate intestine in reverse. The subject was hospitalised and the physician considered the events were clinically significant (or requiring intervention). A plain abdominal x-Ray was performed. It did not showed a visible intussusception or soft tissue mass. It showed fluid levels and dilated bowel loops. The plain abdominal x-ray with air or liquid contrast enema did not demonstrated invagination of the intestine. The plain abdominal x-ray showed non-specific abnormalities. The result of this exam was a suspicious ileocolic invagination. An abdominal ultrasound was not performed. An abdominal CT was not performed. The subject was treated with surgery (intestinal resection and ileocolostomy) without complications. After surgery, the subject presented sepsis, recovering and was discharged on 6 May 2008. At the time of reporting the events were resolved. The physician considered the events were almost certainly related to vaccination with ROTARIX.


Changed on 10/14/2018

VAERS ID: 382966 Before After
VAERS Form:1
Age:0.33
Sex:Female
Location:Foreign
Vaccinated:2007-12-14
Onset:2008-04-04
Submitted:2010-03-18
Entered:2010-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal distension, Abdominal pain, Barium double contrast, Dehydration, Faeces discoloured, Haematochezia, Intussusception, Sepsis, Vomiting, X-ray abnormal, Rectal examination, Ileocolostomy, Intestinal resection, Gastrointestinal motility disorder, Abdominal X-ray

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 32     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Abdominal x-ray, Apr2008, see text
CDC 'Split Type': B0639148A

Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 7-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). Previous and/or concurrent vaccination included 10 valent pneumococcal conjugate vaccine (manufacturer unspecified, intramuscular, unknown injection site) given on 22 August 2007; BCG (non-GSK) (manufacturer unspecified, intradermal, unknown injection site) given on 15 August 2007; HEP B (manufacturer unspecified, intramuscular, unknown injection site) given on 15 August 2007, 22 October 2007 and 18 February 2008; 1st dose of ROTARIX (1 ml, oral) given on 22 October 2007. On 14 December 2007, the subject received 2nd dose of ROTARIX (1 ml, oral). On 4 April 2008, 112 days after vaccination with ROTARIX, the subject experienced abdominal pain, blood in stools, abdominal distension, biliary vomiting. The subject was admitted into emergency room same day and found abdominal distention, dehydrated, abdominal pain, no peristalsis, rectal examination with "blackcurrant" evacuations and palpate intestine in reverse. The subject was hospitalised and the physician considered the events were clinically significant (or requiring intervention). A plain abdominal x-Ray was performed. It did not showed a visible intussusception or soft tissue mass. It showed fluid levels and dilated bowel loops. The plain abdominal x-ray with air or liquid contrast enema did not demonstrated invagination of the intestine. The plain abdominal x-ray showed non-specific abnormalities. The result of this exam was a suspicious ileocolic invagination. An abdominal ultrasound was not performed. An abdominal CT was not performed. The subject was treated with surgery (intestinal resection and ileocolostomy) without complications. After surgery, the subject presented sepsis, recovering and was discharged on 6 May 2008. At the time of reporting the events were resolved. The physician considered the events were almost certainly related to vaccination with ROTARIX.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=382966&WAYBACKHISTORY=ON


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166